Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression

MLA

Yuan Xu, et al. “Rapamycin Suppresses Angiogenesis and Lymphangiogenesis in Melanoma by Downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 Expression.” OncoTargets and Therapy, vol. 12, June 2019, pp. 4643–54. EBSCOhost, https://doi.org/10.2147/ott.s205160.

APA

Yuan Xu, Min Wang, Qian Wang, Si-Ming Yuan, & Guo-Zhong Wen. (2019). Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression. OncoTargets and Therapy, 12, 4643–4654. https://doi.org/10.2147/ott.s205160

Chicago

Yuan Xu, Min Wang, Qian Wang, Si-Ming Yuan, and Guo-Zhong Wen. 2019. “Rapamycin Suppresses Angiogenesis and Lymphangiogenesis in Melanoma by Downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 Expression.” OncoTargets and Therapy 12 (June): 4643–54. doi:10.2147/ott.s205160.